行情

ATHX

ATHX

Athersys
NASDAQ

实时行情|Nasdaq Last Sale

2.590
+0.630
+32.14%
盘前: 2.580 -0.01 -0.39% 07:00 03/31 EDT
开盘
2.060
昨收
1.960
最高
2.650
最低
2.050
成交量
851.76万
成交额
--
52周最高
2.650
52周最低
1.130
市值
4.25亿
市盈率(TTM)
-8.7856
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ATHX价格均价为9.00,最高价位12.00,最低价为6.00。

EPS

ATHX 新闻

更多
  • Athersys Sees 4 Million Share Insider Buy From Partner Running COVID-19 ARDS Trial In Japan
  • Seeking Alpha - Article · 17小时前
  • Mid-Morning Market Update: Markets Open Higher; Cal-Maine Foods Profit Tops Expectations
  • Benzinga · 21小时前
  • ABT, DD among premarket gainers
  • Seeking Alpha - Article · 21小时前
  • HEALIOS K.K. Increases Investment in Athersys by Fully Exercising Warrant to Acquire Additional Shares
  • Business Wire · 1天前

所属板块

生物技术和医学研究
+4.00%
制药与医学研究
+4.75%

热门股票

代码
价格
涨跌幅

ATHX 简况

Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the standard of care is limited or inadequate for many patients.
展开

微牛提供Athersys Inc(NASDAQ-ATHX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ATHX股票新闻,以帮助您做出投资决策。